Abstract
Gastroesophageal reflux disease (GERD) is common in chronic obstructive pulmonary disease (COPD) and is associated with COPD exacerbations. Since macrolides have prokinetic effects and consequently may decrease GERD, we hypothesized that azithromycin may decrease exacerbations by decreasing GERD.
Cite
CITATION STYLE
APA
Ramos, F., Lindberg, S., Krahnke, J., Connett, J., Albert, R., & Criner, G. (2014). Azithromycin and COPD Exacerbations in the Presence or Absence of Symptoms or Active Treatment for Gastroesophageal Reflux. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 1(2), 221–228. https://doi.org/10.15326/jcopdf.1.2.2014.0132
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free